6 August 2020
4DMedical Limited (“4DMedical” or the “Company”), a medical technology Company focused on commercialising its patented respiratory analysis technology, is pleased to announce it will list on the Australian Securities Exchange (ASX) on Friday 7 August. The Company will trade on the ASX under the ticker 4DX.
Following the successful completion of its $55.79 million initial public offering (IPO), the ASX invited the Company to list earlier than indicated in the Prospectus.
Under the IPO the Company issued 76.43 million new shares at $0.73 per share, which was strongly supported by new and existing investors.
More information with regard to 4DMedical’s ASX listing will be made available throughout this week.
